首页> 外文期刊>EJNMMI Research >Inter-observer agreement improves with PERCIST 1.0 as opposed to qualitative evaluation in non-small cell lung cancer patients evaluated with F-18-FDG PET/CT early in the course of chemo-radiotherapy
【24h】

Inter-observer agreement improves with PERCIST 1.0 as opposed to qualitative evaluation in non-small cell lung cancer patients evaluated with F-18-FDG PET/CT early in the course of chemo-radiotherapy

机译:对于非小细胞肺癌患者,在化学放疗过程的早期用F-18-FDG PET / CT进行定性评估,与PERCIST 1.0相比,观察者间的共识有所改善

获取原文
获取外文期刊封面目录资料

摘要

Background The purpose of this study is to determine whether a qualitative approach or a semi-quantitative approach provides the most robust method for early response evaluation with 2′-deoxy-2′-[~(18)F]fluoro- d -glucose (F-18-FDG) positron emission tomography combined with whole body computed tomography (PET/CT) in non-small cell lung cancer (NSCLC). In this study eight?Nuclear Medicine consultants analyzed F-18-FDG PET/CT scans from 35 patients with locally advanced NSCLC. Scans were performed at baseline and after 2?cycles of chemotherapy. Each observer used two different methods for evaluation: (1) PET response criteria in solid tumors (PERCIST) 1.0 and (2) a qualitative approach. Both methods allocate patients into one of four response categories (complete and partial metabolic response (CMR and PMR) and stable and progressive metabolic disease (SMD and PMD)). The inter-observer agreement was evaluated using Fleiss’ kappa for multiple raters, Cohens kappa for comparison of the two methods, and intraclass correlation coefficients (ICC) for comparison of lean body mass corrected standardized uptake value (SUL) peak measurements. Results The agreement between observers when determining the percentage change in SULpeak was “almost perfect”, with ICC?=?0.959. There was a strong agreement among observers allocating patients to the different response categories with a Fleiss kappa of 0.76 (0.71–0.81). In 22 of the 35 patients, complete agreement was observed with PERCIST 1.0. The agreement was lower when using the qualitative method, moderate, having a Fleiss kappa of 0.60 (0.55–0.64). Complete agreement was achieved in only 10 of the 35 patients. The difference between the two methods was statistically significant ( p ?
机译:背景技术本研究的目的是确定定性方法或半定量方法是否为2'-deoxy-2'-[〜(18)F]氟-d-葡萄糖( F-18-FDG)正电子发射断层显像结合全身计算机断层显像(PET / CT)在非小细胞肺癌(NSCLC)中的应用。在这项研究中,八位核医学顾问对35例局部晚期NSCLC患者的F-18-FDG PET / CT扫描进行了分析。在基线和化疗2周后进行扫描。每个观察者使用两种不同的评估方法:(1)实体瘤的PET反应标准(PERCIST)1.0和(2)定性方法。两种方法都将患者分为四个反应类别之一(完全和部分代谢反应(CMR和PMR)以及稳定和进行性代谢疾病(SMD和PMD))。使用多个评估人的Fleiss'kappa,用于两种方法比较的Cohens kappa和用于比较瘦体重校正的标准摄取值(SUL)峰值测量值的组内相关系数(ICC),评估了观察员之间的协议。结果确定SULpeak的百分比变化时,观察者之间的协议“几乎是完美的”,ICC?=?0.959。观察者之间的共识是,将患者分配到不同的反应类别,其Fleiss kappa为0.76(0.71-0.81)。在35名患者中,有22名患者与PERCIST 1.0完全一致。当使用定性方法时,一致性较低,Fleiss kappa为0.60(0.55-0.64)。 35位患者中只有10位完全达成协议。两种方法之间的差异具有统计学意义(p≤0.005)(卡方)。比较每个观察者的两种方法,得出科恩的kappa值介于0.64到0.79之间,这表明这两种方法之间有很强的一致性。结论在对NSCLC患者的早期治疗反应进行分类时,与定性方法相比,PERCIST 1.0在观察者之间提供了更高的总体一致性。实际上,使用PERCIST 1.0时,即使为了模仿日常情况而将指令级别保持在最低水平,观察者之间的协议也很牢固。可变性很大程度上归因于该方法的主观因素。电子补充材料本文的在线版本(doi:10.1186 / s13550-016-0223-6)包含补充材料,授权用户可以使用。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号